CHRONIC
FATIGUE/ IMMUNE DYSFUNCTON SYNDROME
(CFIDS)
Chronic Fatigue Syndrome (CFIDS) affects
1/2 to 1% of the U.S. population. It
crosses all boundaries of race, sex, and
socioeconomic factors. CFIDS is a debilitating
illness that is characterized by prolonged
fatigue. Although many conditions can
cause fatigue, the fatigue experienced by
people with CFIDS is persistent or recurrent,
causing debilitating tiredness in with no
apparent reason. Fatigue forces people
with CFIDS to substantially reduce their
occupational, educational, social and personal
activities. Fatigue in CFIDS is not due to
ongoing work or exertion and is not
substantially relieved by rest. In
addition, people with CFIDS often report a
variety of other problems including, problems
with short-term memory and concentration,
tender lymph nodes, muscle and joint pain and
headaches.1
In
1869, a physician described undue fatigue,
which he termed neurasthenia. This was the
first time it had been “officially”
described in medical literature. In
contemporary vernacular, the terms “Myalgic
Encephalitis”, “Yuppie Flu or Plague”
and “Shirker’s Syndrome” have been used
to describe this problem. The search for
causes of this problem has been going on for
more than 100 years. The major emphasis has
been searching for an elusive agent as the
cause: Epstein-Barr virus and more recently
retroviruses. In 1985, the CDC formulated a
set of criteria for the diagnosis of what is
now called chronic fatigue and immune
dysfunction syndrome. Currently, nearly a
quarter of all patients presenting to their
physicians do so with a complaint of “chronic
fatigue.”
There
are many illnesses that have chronic fatigue
as a major symptom: depression, autoimmune
disease, environmental illness and the classic
viral illness. All of these illnesses may have
a similar basis for their development—molecular
damage from oxidative intracellular stressors. The
state of chronic fatigue cannot be understood
through simplistic single-agent,
single-disease model. What is required is a
holistic study of the biochemistry of man and
his environment including: possible organisms,
chemical and heavy metal damage, digestion,
nutritional (anti-oxidant, etc.) deficiencies,
and stresses of modern life. The recognition
of the “flaws” or damaged areas from
molecular injury and their elimination is the
only way to solve the puzzle of “chronic
fatigue.” This can be done by a meticulous
investigation into the various body systems
from a functional molecular standpoint. In
this way, the causes of the problem may be
determined so that curative measures may be
employed.
When
we think of a patient with “chronic fatigue”
we must be very specific about the
characteristics of the complaints the patient
has because there are various types of
syndrome complexes that fall under the general
description of “chronic fatigue.” The
Centers for Disease Control (CDC) published
guidelines to diagnose CFIDS (herein
modified):
-
Fever
and/or chills.
-
Sore,
scratchy relapsing, throat problem.
-
Lymphatic
soreness or palpable swelling in at
least two sites.
-
Muscle
discomfort, flu-like muscle aches;
sore muscles to touch.
-
Post-exertional
malaise lasting more than 24 hours.
-
Muscle
pain in 8 out of 18 classic trigger
points.
-
Generalized
weakness.
-
Joint
discomfort: migratory and asymmetrical
involving large joints more than
small.
-
Multi-joint
pain without swelling or redness
-
Headache
- new onset, pressure type:
retro-orbital and occipital that
worsens with stress and
exertion, or of a new type, pattern or
severity
-
Sleep
disturbances and hypersomnolence
(10/hrs/night, plus naps).
-
Chronic
frequent nausea.
CFIDS
is a complex illness characterized by
incapacitating fatigue (experienced as
exhaustion and extremely poor stamina),
neurological problems and a constellation of
symptoms that can resemble other disorders,
including: mononucleosis, multiple sclerosis,
fibromyalgia, AIDS-related complex (ARC), Lyme
disease, post-polio syndrome and autoimmune
diseases such as lupus. These symptoms tend to
wax and wane but are often severely
debilitating and may last for many months or
years. All segments of the population
(including children) are at risk, but women
under the age of 45 seem to be the most
susceptible.
CFIDS
represents one type of “chronic fatigue”
that affects a small group of patients. A
larger group of “fatigue” illnesses don’t
meet these criteria but the patients are just
as ill. These are
caused by other factors like: heavy metal
toxicity, chemical toxicity, depression,
nutritional deficiencies and many others.
Causes
Research
suggests that CFIDS results from a dysfunction
of the immune system. The exact nature of this
dysfunction is not yet well defined, but it
can generally be viewed as an upregulated or
overactive state (which is responsible for
many of the symptoms). Ironically, there is
also evidence of some immune suppression in
CFIDS; patients exhibit certain down-regulated
signs. For example, in many patients there are
functional deficiencies in natural killer
cells (an important immune system component
responsible for protection against viruses).
Based on physical and laboratory findings,
many scientists are convinced that viruses are
associated with CFIDS and may be directly
involved in causing the disease. Since the
discovery (or rediscovery) of CFIDS in the
United States in the mid -1980s, several
viruses continue to be—studied to determine
what, if any, part they play in the disease.
These include enteroviruses, herpes viruses
(especially human herpes virus-6 or HHV-6),
and newly discovered retroviruses. In the
first few years of this research, it was
thought that the Epstein-Barr virus (EBV), a
herpes virus that causes mononucleosis, was
the cause of this syndrome. However,
researchers now believe that EBV activation
(when it exists) is a result or complication
of CFIDS rather than its cause. To date, no
virus has been conclusively shown to be an
essential element of CFIDS. Accordingly,
research efforts are still directed toward
identifying and isolating the fundamental
agent(s) responsible for triggering immune
system disruption in persons with CFIDS (PWCs).
Additionally, there are on-going factors (such
as genetic predisposition, age, sex, prior
illness, other viruses, environment and
stress), which appear to play an important
role in the development and course of the
illness.
Is
CFIDS Contagious? It is probable that the
viruses and/or other agents that trigger CFIDS
are transmissible. CFIDS has been reported in
many children and monogamous adults and “clustering”
of cases in families, workplaces and
communities also seems to occur. Anecdotal
reports exist of pets of CFIDS patients
getting unusual diseases. Whether a person
develops CFIDS is believed to be a function of
how his/her system deals with the causative
agent(s). However, most people in close
contact with CFIDS patients have not developed
the illness.
Symptoms
PWCs
experience symptoms, which tend to be very
individualistic and to fluctuate in severity.
According to the CDC case definition, symptoms
may include: prolonged fatigue, especially
after exercise levels that would have been
easily tolerated before; low grade fever; sore
throat; painful lymph nodes; muscle weakness;
muscle discomfort or myalgia (pain or aching);
sleep disturbance (unrefreshing sleep,
hypersomnia or insomnia); headaches of a new
type, severity, or pattern; migratory
arthralgias (joint pain) without joint
swelling or redness; neuropsychologic problems
including photophobia, transient visual
scotomata (spots), forgetfulness,
irritability, confusion, difficulty thinking/
inability to concentrate, anxiety, panic
attacks, personality changes, mood swings and
depression. Other symptoms common to CFIDS
include other cognitive function problems
(such as spatial disorientation and dyslogia -
impairment of speech and/or reasoning); chills
and night sweats; shortness of breath;
dizziness and balance problems; sensitivity to
heat and cold; intolerance of alcohol;
irregular heartbeat; abdominal pain, diarrhea;
irritable bowel (abdominal pain, diarrhea,
constipation, intestinal gas) dryness of the
mouth and eyes (sicca syndrome); hearing
disorders or sensitivity, ringing in the ears
(tinnitus); menstrual problems including PMS
and endometriosis; hypersensitivity of the
skin; chest pains; rashes; allergies and
sensitivities to odors, chemicals and
medications; weight changes without changes in
diet; hair loss; lightheadedness - feeling “in
a fog”; fainting; muscle twitching;
seizures.
Diagnosis
Dealing
with CFS first requires getting an accurate
diagnosis. However, since there are no
specific blood tests, x-rays or other
definitive means to confirm CFS, testing
serves to rule out other possible causes of
the symptoms. Most physicians base their
diagnosis of CFIDS on a “working case
definition” developed by the CDC (see above)
As the cause and mechanism of this disease
become clear so will the clinical and
laboratory parameters which define CFIDS.
Ultimately, conclusive diagnostic standards
will be developed and accepted. Unfortunately,
many physicians are not very familiar with
CFIDS and have difficulty diagnosing it.
Others still do not even know or believe
that the illness
exists. As a result, PWCs are often
misdiagnosed, sometimes as having a
psychosomatic or affective disorder because
such conditions are also diagnosed by
exclusion in many cases.
The
diagnostic process may be lengthy - some
persons wait many months (or years) to be
diagnosed. It may take an enormous amount of
patience. In the meantime, talk with your
doctor to work out the best treatment plan for
symptom relief and to improve function.
Treatment
Treating
chronic fatigue and immune dysfunction
syndrome (CFIDS) presents a significant
challenge to persons with CFIDS and their
physicians. As yet, there is no known cause,
cure, or universal treatment for CFIDS. Until
a treatment is developed which will improve
all the symptoms of CFIDS, or correct the
underlying cause, therapy is based upon the
individual's presenting symptoms. No primary
therapy has been proven to cure CFIDS. Several
experimental drugs have been tested in limited
clinical trials. While the results have been
encouraging, further trials must be conducted
and evaluated before approval. Avoidance of
environmental irritants and certain foods can
sometimes relieve symptoms and many PWCs claim
to have benefited from nutritional therapies.
A significant percentage of PWCs show marked
improvement over time, but many remain ill or
cycle through a continuing series of
remissions and relapses. The symptoms in
severely affected PWCs can be devastating and
result in prolonged interruption of work and
family life.
Medical
Treatments
-
Medications that provide symptom relief
are frequently the first line of treatment
chosen by primary care providers for the
person with CFIDS. These include medications
for pain, sleep disturbances; digestive
problems such as nausea; flu-like symptoms and
if present depression and anxiety. Medications
may be supplemented by supportive therapies.
Alternative
Treatment - Many persons find
complementary therapies such as acupuncture,
Tai Chi, and alternative food and herbal
supplements, herbal immuno-modulating
products, acemannan (extract from aloe vera
plant), thymus therapy, biooxidative therapy
(ozone, hydrogen peroxide), transfer factor,
mega nutrient IV therapy, viral neutralization
and orthomolecular therapy
to be helpful. Please note that
adding food and herbal supplements to your
therapy regimen needs to be done with care and
with your physician's and pharmacist's
knowledge to prevent undesirable side effects.
Lifestyle
Alterations - Altered digestion, food
intolerances, decreased energy, fatigue,
cognitive problems, and sleeplessness create
the need for revisions in daily living
routines. These can include changes in diet;
exercise modifications; alterations in
activities of daily living according to one's
energy level; and sleep/rest management. All
may require the assistance of professional
clinicians, such as a dietitian, physical
and/or occupational therapist, mental health
professional, and sleep therapist.
Supportive
Treatments - Therapies that help persons
to relax and improve coping skills fall into this category and may include counseling for emotional
and mental health, cognitive behavioral
therapy, sleep management therapy, and
massage.
Other
Treatment Options - For persons who have
been diagnosed with an autonomic nervous
system abnormality such as Orthostatic
Intolerance, fluid and salt loading may be a
treatment of choice.
Treatment
may incorporate any, or all, of the above
categories as persons with CFIDS seek to
improve their condition. The person with CFIDS
can experience much frustration when
attempting to secure treatment. Keeping
an open mind and speaking candidly with a
health care provider is important to any
treatment plan.
Some
researchers believe that PWCs may also be at
greater risk of developing other illnesses.
However, the extent to which CFIDS may be
progressive or degenerative is not yet known.
There
is currently no "cure" for CFIDS and
unless a specific cause is identified,
treatments are trial and error. What works for
one person, may not work for you, or may
actually aggravate your symptoms. Some
medications may help reduce some symptoms.
Some changes in diet and daily routine may
also help. You should be well informed about
whatever treatment you choose.
As
with many chronic illnesses, CFIDS is complex
and poorly understood. Education is the key.
There are many resources available to help,
including other people with CFS, healthcare
professionals, books and magazines and of
course, the Internet.
The following resources and links are some reliable sources of
information about CFIDS:
Running
on Empty, The Complete Guide to CFS (CFIDS)
by Katrina Berne, Ph.D., 1995
http://www.cdc.gov/ncidod/diseases/cfs/
- This web site offers information about chronic
fatigue syndrome CFS) and its diagnosis and
treatment.
1
http://www.umdnj.edu/cfsweb/CFS/cfshome.html
- Dr. Benjamin Natelson is the author of Facing
and Fighting Fatigue: A Practical Approach.
http://www.aacfs.org/html/contempo.htm
- This link is an abstract of
"Linking Evidence and Experience: Chronic
Fatigue Syndrome" by Benjamin H.
Natelson, M.D. which appeared in JAMA vol 285,
No.20, May23/30, 2001.
http://www.cfs-news.org/nih.htm
- An assembly of all the links at NIH concerning
Chronic Fatigue Syndrome.
|